Sector Update: Healthcare Shares Mixed Pre-Market; Sinovac Soaring 10% on Q2 Results

By
A A A

Top Healthcare Stocks:

JNJ: +0.33%

PFE: -0.24%

ABT: -0.11%

MRK: flat

AMGN: flat

Healthcare shares are flat to higher in pre-market trade. Sinovac Biotech Ltd. ( SVA ) share are soaring 10% at $4.70 after it reported Q2 2013 net income of $1.3 million, or $0.02 per share, compared to a net loss of $1.6 million, or $0.03 per share, in the same period last year. Sales increased by 86.4% to $17.5 million from $9.4 million.

No analyst estimates were available for comparison. SVA is trading within a 52-week range of $2.13 - $5.09.

And, Savient Pharmaceuticals ( SVNT ) is down 1.4% at $0.70 as it says Q2 net loss was $0.35 per share on sales of $6.7 million. The Thomson Reuters mean was for a $0.31 per share loss on sales of $5.84 million.

Finally, Syneron Medical ( ELOS ) said Q2 earnings fell to $0.02 per share from $0.05 the year earlier, missing the $0.09 average analyst estimate. Total revenues rose 1% to $68.8 million, shy of the $70.9 million consensus estimate. ELOS closed up 2.21% yesterday at $9.25.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: ELOS , SVA , SVNT

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

100%
50%

Most Active by Volume

183,639,073
  • $42.32 ▲ 3.85%
82,623,623
  • $15.99 ▼ 22.79%
39,547,942
  • $119 ▲ 1.19%
32,107,751
  • $77.62 ▲ 2.63%
29,684,848
  • $10.60 ▲ 2.02%
27,615,309
  • $24.03 ▲ 0.38%
26,917,669
  • $31.10 ▲ 2.07%
26,464,306
  • $47.75 ▲ 0.59%
As of 11/26/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com